AngioDynamics ANGO Med Tech — Gross Margin %
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept ango:GrossMarginPercentage.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's med tech — gross margin %.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's med tech — gross margin %?
- AngioDynamics (ANGO) reported med tech — gross margin % of 62.5% in Q4 2025.
- How has AngioDynamics's med tech — gross margin % changed year-over-year?
- AngioDynamics's med tech — gross margin % decreased by 0.0% year-over-year, from 62.5% to 62.5%.
- What is the long-term trend for AngioDynamics's med tech — gross margin %?
- Over 3 years (2021 to 2024), AngioDynamics's med tech — gross margin % has grown at a 38.6% compound annual growth rate (CAGR), from 71% to 188.9%.
- What does med tech — gross margin % mean?
- Gross margin percentage represents the proportion of net sales remaining after deducting the direct costs of goods sold for the Med Tech segment. It is a key performance indicator of manufacturing efficiency, product mix, and pricing strategy. A higher margin indicates that the segment is effectively managing production costs relative to its revenue generation.